Vol. 17/No. 7 | OncologyLive

This Giant of Cancer Care Made Bridging the Fairness Gap His Lifelong Quest

April 03, 2016

Harold P. Freeman, MD, who developed the patient navigation concept now used widely in cancer care, was honored in the Community Outreach/Education category with a 2015 Giants of Cancer Care® award, a program that the Intellisphere® Oncology Specialty Group launched to honor leaders in the field.

TILs Advancing as Melanoma Immunotherapy Option

March 31, 2016

After nearly 30 years of research, tumor-infiltrating lymphocyte technology is being investigated as a means of producing personalized immunotherapy for patients with metastatic melanoma in a small clinical trial that may help open the door for broader application in other solid tumor types.

VEGF Remains Central Target for Antiangiogenic Therapy Despite Challenges

March 31, 2016

Early expectations of antitumor activity across all cancer types have been tempered by clinical disappointment in many cases and only modest efficacy in others. Nonetheless, VEGF signaling continues to present a promising target.

Novel Entrectinib Trial Focuses on Gene Rearrangements Across Many Tumor Types

March 30, 2016

Researchers have designed a recently launched clinical study into entrectinib, a first-in-class inhibitor of tropomyosin receptor kinases, as a basket trial in which the drug can be evaluated simultaneously for activity against three gene alterations and multiple tumor types.

Killing Cancer: What Vincent DeVita Wants You to Know

March 30, 2016

Vincent T. DeVita Jr, MD, discusses his insights into the operations of the FDA and the National Cancer Institute will hold a special appeal for oncology specialists and healthcare providers in his book, "The Death of Cancer."

Rehabilitation Should Be Part of Cancer Treatment

March 27, 2016

Rehabilitation is medical care that cancer patients should expect and that it should be delivered by trained rehabilitation professionals: physiatrists, physical therapists, occupational therapists, or speech language pathologists.

Combination Therapies Explored in Pancreatic Cancer Subgroups

March 25, 2016

To address the unmet need for better diagnostic and therapeutic modalities in pancreatic cancer, investigators at the Indiana University School of Medicine have established the Pancreatic Cancer Signature Center at the Indiana University Melvin and Bren Simon Cancer Center.